Advertisement: TTP
Mid banner advertisement: BDO
Advertisement Cambridge China Centre
RealVNC mid-banner general
Advertisement: Mogrify
Advertisement: Bradfield Centre mid
RealVNC mid banner careers
ARM Innovation Hub
Advertisement: RSM
Advertisement: Wild Knight Vodka
Advertisement EY mid banner
Advertisement: Cambridge Network
Barr Ellison Solicitors – commercial property
12 July, 2012 - 13:14 By News Desk

Innovative Drug Entity: Treatment of Neuropathic Pain

An Israel-based bio-pharmaceutical company is developing a new chemical entity for the treatment of neuropathic pain. In pre-clinical studies conducted, this drug shows high efficacy with an improved safety profile. The drug was found to be more effective than currently used anti-pain drugs in animal models. The company is seeking a partner for co-development and eventual commercialisation of this product.Ref: 12 IL 80EP 3O3R

Add new comment

Newsletter Subscription

Stay informed of the latest news and features